Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53

Journal of Virology

Volumn 79, Issue 14, 2005, Pages 8773-8783

  Stewart, Deborah ^a   Ghosh, Anirban ^a   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; PROTEIN E6; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; NUCLEAR EXPORT SIGNAL; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR SUPPRESSOR GENE; UBIQUITINATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CYTOPLASM; DNA-BINDING PROTEINS; MICE; NIH 3T3 CELLS; ONCOGENE PROTEINS, VIRAL; PROTEIN TRANSPORT; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

HUMAN PAPILLOMAVIRUS TYPE 18; PAPILLOMAVIRUS;

EID: 21644475388     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.14.8773-8783.2005     Document Type: Article

References (39)

1. Banks, L., G. Matlashewski, and L. Crawford. 1986. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159:529-534.
2. Boyd, S. D., K. Y. Tsai, and T. Jacks. 2000. An intact MDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2:563-568.
3. Camus, S., M. Higgins, D. Lane, and S. Lain. 2003. Differences in the ubiquitination of p53 by Mdm2 and HPV protein E6. FEBS Lett. 536:220-224.
4. 3a. Courtois, S., G. Verhaegh, S. North, M. G. Luciani, P. Lassus, U. Hibner, M. Oren, and P. Hainaut, 2002. ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counters growth suppression by wild-type p53. Oncogene 21:6722-6728.
5. Crook, T., C. Fisher, P. J. Masterson, and K. H. Vousden. 1994. Modulation of transcriptional regulatory properties of p53 by HPV E6. Oncogene 9:1225-1230.
6. Davies, R., R. Hicks, T. Crook, J. Morris, and K. H. Vousden. 1993 Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol. 67:2521-2528.
7. Donehower, L. 1996. The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol. 7:269-278.
8. Dyson, N., P. Howley, K. Münger, and E. Harlow. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-936.
9. Freedman, D., and A. J. Levine. 1998. Nuclear export is required for degradation of endogenous p53 by Mdm2 and human papillomavirus E6. Mol. Cell. Biol. 18:7288-7293.
10. Gavioli, R., T. Frisan, S. Vertuani, G. W. Bornkamm, and M. G. Masucci. 2001. c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nat. Cell Biol. 3:283-288.
11. Geyer, R. K., Z. K. Yu, and C. G. Maki. 2000. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2:569-573.
12. Ghosh, A., D. Stewart, and G. Matlashewski. 2004. Regulation of human p53 activity and cell localization by alternative splicing. Mol. Cell. Biol. 24:7987-7997.
13. Grossman, S. R., M. E. Deato, C. Brignone, H. M. Chan, A. L. Kung, H. Tagami, Y. Nakatani, and D. M. Livingston. 2003. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300:342-344.
14. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
15. 13a. Hengstermann, A., L. Linares, A. Ciechanover, N. Whitaker, and M. Scheffner. 2001. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad. Sci. USA 98:1218-1223.
16. Hietanen, S., S. Lain, E. Krausz, C. Blattner, and D. P. Lane. 2000. Activation of p53 in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci. USA. 97:8501-8506.
17. Hollenstein, M., K. Rice, M. S. Greenblatt, T. Soussi, R. Fuchs, T. Sorlie, E. Hovig, B. Smith-Sorensen, R. Montesano, and C. C. Harris. 1994. Database of p53 gene somatic mutations in human tumours and cell lines. Nucleic Acids Res. 22:3551-3555.
18. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein Mdm2 is a ubiquitin ligase E3 for tumour suppressor p53. FEBS Lett. 420:25-27.
19. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
20. Lai, Z., K. V. Ferry, M. A. Diamond, K. E. Wee, Y. B. Kim, J. Ma, T. Yang, P. A. Benfield, R. A. Copeland, and K. R. Auger. 2001. Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J. Biol. Chem. 276:31357-31367.
21. Leng, R. P., Y. Lin, W. Ma, H. Wu, B. Lemmers, S. Chung, J. M. Parant, G. Lozano, R. Hakem, and S. Bencnimol. 2003. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112:779-791.
22. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
23. Li, M., C. L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu. 2003. Mono- vs polyubiquitination: differential control of p53 fate by Mdm2. Science 302:1972-1975.
24. Li, X., and P. Coffino. 1996. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J. Virol. 70:4509-4516.
25. 21a. Lohrum, M. A., D. B. Woods, R. L. Ludwig, E. Balint, and K. H. Vousden. 2001. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 21:8521-8532.
26. Malkin, D., F. Li, L. Strong, J. Fraumini, C. Nelson, D. Kim, J. Kassel, M. Gryka, F. Bischoff, M. Tainsky, and S. Friend. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasias. Science 250:1233-1238.
27. Masson, M., C. Hindelang, A. P. Sibler, G. Schwalbach, G. Travé, and E. Weiss. 2003. Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical cancer cells. J. Gen. Virol. 84:2099-2104.
28. O'Keefe, K., H. Li, and Y. Zhang. 2003. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation by not ubiquitination. Mol. Cell. Biol. 23:6396-6405.
29. Phelps, W. C., S. Bagchi, J. A. Barnes, R. Raychaudhuri, V. Kraus, K. Münger, P. M. Howley, and J. R. Nevins. 1991. Analysis of trans-activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J. Virol. 65:6922-6930.
30. Roth, J., M. Dobbelstein, D. A. Freedman, T. Shenk, and A. J. Levine. 1998. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17:554-564.
31. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
32. Shirangi, T. R., A. Zaika, and U. M. Moll. 2002. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. FASEB J. 16:420-432.
33. Stewart, D., S. Kazemi, S. Li, P. Massimi, L. Banks, A. E. Koromilas, and G. Matlashewski. 2004. Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. J. Gen. Virol. 85:1419-1426.
34. Stommel, J. M., N. D. Marchenko, G. S. Jimenez, U. M. Moll, T. J. Hope, and G. M. Wahl. 1999. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18:1660-1672.
35. Werness, B., A. Levine, and P. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
36. Xirodimas, D. P., C. W. Stephen, and D. P. Lane. 2001. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. Exp. Cell Res. 270:66-77.
37. 32a. Yin, Y., C. W. Stephen, M. G. Luciani, and R. Fahraeus. 2002. p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat. Cell Biol. 4:462-467.
38. Yu, Z. K., R. K. Geyer, and C. G. Maki. 2000. MDM2-dependent ubiquitination of nuclear and cytoplasmic p53. Oncogene 19:5892-5897.
39. zur Hausen, H. 1991. Viruses in human cancers. Science 254:1167-1173.